Study suggests epiregulin as target in lung cancer

Latest Science News -- ScienceDaily - Hace 6 horas

A new potential biomarker and target has been identified in lung cancer, namely epiregulin, an under-studied EGF-like growth factor. This discovery led researchers to question whether this upregulation was happenstance, correlative, or in fact causative in the disease.